VUF 11222

Pricing Availability   Qty
Description: High affinity non-peptide CXCR3 agonist
Chemical Name: 2'-Bromo-N-[[(1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl]methyl]-N,N-dimethyl-[1,1'-biphenyl]-4-methanaminium iodide
Purity: ≥98% (HPLC)
Datasheet
Citations
Reviews
Literature (1)

Biological Activity for VUF 11222

VUF 11222 is a high affinity non-peptide CXCR3 agonist (pKi = 7.2).

Technical Data for VUF 11222

M. Wt 552.33
Formula C25H31BrIN
Storage Store at -20°C
Purity ≥98% (HPLC)
CAS Number 1414376-84-3
PubChem ID 71459294
InChI Key IXXWHYDKYNWDKJ-IUQUCOCYSA-M
Smiles C[N+](CC1=CC=C(C2=CC=CC=C2Br)C=C1)(C)CC3=CC[C@H]4C[C@@H]3C(C)4C.[I-]

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for VUF 11222

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 55.23 100
ethanol 5.52 10 with gentle warming

Preparing Stock Solutions for VUF 11222

The following data is based on the product molecular weight 552.33. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.81 mL 9.05 mL 18.11 mL
5 mM 0.36 mL 1.81 mL 3.62 mL
10 mM 0.18 mL 0.91 mL 1.81 mL
50 mM 0.04 mL 0.18 mL 0.36 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

References for VUF 11222

References are publications that support the biological activity of the product.

Wijtmans et al (2012) Chemical subtleties in small-molecule modulation of peptide receptor function: the case of CXCR3 biaryl-type ligands. J.Med.Chem. 55 10572 PMID: 23150943


If you know of a relevant reference for VUF 11222, please let us know.

View Related Products by Target

View Related Products by Product Action

View all Chemokine CXC Receptor Agonists

Keywords: VUF 11222, VUF 11222 supplier, High, affinity, non-peptide, CXCR3, agonists, Chemokine, CXC, Receptors, 5668, Tocris Bioscience

Citations for VUF 11222

Citations are publications that use Tocris products.

Currently there are no citations for VUF 11222. Do you know of a great paper that uses VUF 11222 from Tocris? Please let us know.

Reviews for VUF 11222

There are currently no reviews for this product. Be the first to review VUF 11222 and earn rewards!

Have you used VUF 11222?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Rheumatoid Arthritis Poster

Rheumatoid Arthritis Poster

Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune disease that results from a breakdown in immune tolerance, for reasons that are as yet unknown. This poster summarizes the pathology of RA and the inflammatory processes involved, as well as describing some of the epigenetic modifications associated with the disease and the potential for targeting these changes in the discovery of new treatments.